Merck said on Tuesday it has opened a $1-billion facility at its North Carolina site, the latest drugmaker to boost its U.S.
While the company is in discussions to acquire SpringWorks, it did not elaborate on these talks in its earnings call.
A federal judge in North Carolina on Tuesday granted an order for summary judgment in favor of Merck (NYSE:MRK) regarding ...
Merck's injected version of its blockbuster cancer drug Keytruda could face a potential patent challenge from biotech ...